CYTOKINES AND CLINICAL GENE-THERAPY

[1] ANDERSON WF, 1994, HUM GENE THER, V5, P417

[2] EXPRESSION OF MURINE INTERLEUKIN-7 IN A MURINE GLIOMA CELL-LINE RESULTS IN REDUCED TUMORIGENICITY INVIVO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) : 3850 - 3854

[3] ASHER AL, 1991, J IMMUNOL, V146, P3227

[4] TUMOR SUPPRESSION AFTER TUMOR-CELL TARGETED TUMOR-NECROSIS-FACTOR-ALPHA GENE-TRANSFER [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) : 1047 - 1052

[5] PHASE-I STUDY OF CYTOKINE-GENE MODIFIED AUTOLOGOUS NEUROBLASTOMA-CELLS FOR TREATMENT OF RELAPSED REFRACTORY NEUROBLASTOMA [J]. HUMAN GENE THERAPY, 1992, 3 (06) : 665 - 676

[6] CASSILETH P, 1994, HUM GENE THER, V5, P125

[7] GRANULOCYTE COLONY-STIMULATING FACTOR GENE-TRANSFER SUPPRESSES TUMORIGENICITY OF A MURINE ADENOCARCINOMA INVIVO [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) : 889 - 897

[8] DASGUPTA TK, 1994, HUM GENE THER, V5, P94

[9] REDUCED TUMORIGENICITY OF FIBROSARCOMAS WHICH CONSTITUTIVELY GENERATE IL-1-ALPHA EITHER SPONTANEOUSLY OR FOLLOWING IL-1-ALPHA GENE-TRANSFER [J]. INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (05) : 822 - 830

[10] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3539 - 3543

[1] ANDERSON WF, 1994, HUM GENE THER, V5, P417

[2] EXPRESSION OF MURINE INTERLEUKIN-7 IN A MURINE GLIOMA CELL-LINE RESULTS IN REDUCED TUMORIGENICITY INVIVO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) : 3850 - 3854

[3] ASHER AL, 1991, J IMMUNOL, V146, P3227

[4] TUMOR SUPPRESSION AFTER TUMOR-CELL TARGETED TUMOR-NECROSIS-FACTOR-ALPHA GENE-TRANSFER [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) : 1047 - 1052

[5] PHASE-I STUDY OF CYTOKINE-GENE MODIFIED AUTOLOGOUS NEUROBLASTOMA-CELLS FOR TREATMENT OF RELAPSED REFRACTORY NEUROBLASTOMA [J]. HUMAN GENE THERAPY, 1992, 3 (06) : 665 - 676

[6] CASSILETH P, 1994, HUM GENE THER, V5, P125

[7] GRANULOCYTE COLONY-STIMULATING FACTOR GENE-TRANSFER SUPPRESSES TUMORIGENICITY OF A MURINE ADENOCARCINOMA INVIVO [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) : 889 - 897

[8] DASGUPTA TK, 1994, HUM GENE THER, V5, P94

[9] REDUCED TUMORIGENICITY OF FIBROSARCOMAS WHICH CONSTITUTIVELY GENERATE IL-1-ALPHA EITHER SPONTANEOUSLY OR FOLLOWING IL-1-ALPHA GENE-TRANSFER [J]. INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (05) : 822 - 830

[10] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3539 - 3543